Get Healthy!

Artificial intelligence (AI) can help assess lung cancer risk in nonsmokers, a new study shows.

The "CXR-Lung-Risk"AI program evaluates routine chest X-ray images, looking for patterns associated with lung cancer, researchers said.

People whose chest X-rays were flagged by the AI program had twice the risk of developing lung cancer as those whose images were deemed low-risk, accordi...

Everyone knows smoking to be a major cause of cancer.

Now, exactly how tobacco smoke triggers tumor development just got a bit clearer, thanks to new Canadian research.

According to a team at the Ontario Institute for Cancer Research (OICR) in Toronto, smoking appears to prevent the formation of proteins that work to keep runaway cell development in check.

According t...

For smokers and former smokers, getting annual CT scans of the chest to catch lung cancers early dramatically improves survival, new research shows.

Many people may believe lung cancer to be swiftly fatal. However, the new report found that 81% of people whose tumors had been spotted by CT screenings were still alive 20 years later.

And if patients were lucky enough to have their ca...

The American Cancer Society has expanded its recommendations for who should get lung cancer screening.

The updated guidance now says annual screening should start at a younger age and among those who smoke less, and it should continue regardless of how many years ago a former smoker may have quit.

"If you are a person who formerly smoked, once 15 years had elapsed since your cessati...

While U.S. policymakers have restricted flavored vapes to make e-cigarettes less appealing to young people, that plan may be backfiring.

A new study found that for every 0.7 milliliters of "e-liquid"for e-cigarettes that isn't sold because of flavor restrictions, an additional 15 traditional cigarettes were sold.

New research uncovers troubling trends for lung cancer in young and middle-aged women.

Cancer incidence in young women is higher than it is in men, a continuing trend, and now that extends to women over age 50, reversing historical patterns.

"These findings are very concerning,"said study lead author

For a subset of patients with advanced lung cancer, radiation therapy can sometimes substantially extend their lives.

Now a new study hints that a blood test could be used to identify the people most likely to benefit.

Right now, there is no way to cure stage 4, or metastatic,...

As cannabis use has become legal in many U.S. states for medical or recreational use, Americans' views on the drug may have gotten rosier.

In fact, a new report finds that over 44% of adults now believe smoking weed each day is safer than inhaling tobacco smoke.

That perception is counter to the science, however, and could have a serious impact on public health.

"The research...

Millions of American smokers suffer from a potentially serious lung disease that's not technically chronic obstructive pulmonary disease (COPD), a new study finds.

They would benefit from a clear diagnosis, though, and the new findings demonstrate a major gap in care for people with a history of tobacco use, the researchers said.

Among folks who smoked at least one pack of cigaret...

A man's cardio fitness might influence whether he'll develop -- or survive -- three of the most common cancers in males, a new Swedish study reports.

Higher levels of cardio fitness are associated with a significantly lower risk of developing colon and lung cancers, researchers report.

Cardio fitness also plays a role in a man's likelihood of surviving prostate, colon and lung cance...

Cancer death rates among Hispanic Americans have declined in general over the past two decades, but for certain cancers the outlook has only gotten worse, a new study finds.

First, the good news: Thanks to improvements in screening, diagnosis and treatment -- and a decline in smoking -- the U.S. cancer death rate has been dropping for years. And the new study found that this is true of Hi...

The lung cancer drug alectinib (Alecensa) is more potent when taken with a fuller breakfast, or lunch, than when taken with a low-fat breakfast, researchers report.

The Dutch team evaluated 20 patients who took one of two daily doses of alectinib with either low-fat yogurt alone, a full continental breakfast, or a lunch of their choosing. Low-fat yogurt resulted in 14% less exposure to t...

For patients battling late-stage lung cancer, prospects for survival have improved significantly since the advent of medications known as immune checkpoint inhibitors.

But exactly how long patients with advanced non-small cell lung cancer (NSCLC) need to be on immunotherapy has not been known. Until now.

According to new research involving more than 1,000 patients, those with stable...

Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows.

The results could have major implications for patients whose cancers carry a mutation in a gene known as EGFR, which is implicated in the out-of-control cellular growth driving a tumor. Tagrisso appears to...